logo
Share SHARE
FONT-SIZE Plus   Neg

Zimmer Receives FDA Nod To Market IASSIST Knee - Quick Facts

Zimmer Holdings, Inc. (ZMH), announced Thursday that it has received a 510(k) clearance from the U.S. Food and Drug Administration or FDA, enabling it to market iASSIST Knee, the company's personalized guidance system for knee replacement procedures.

The iASSIST Knee technology which comprises small electronic disposable pod components, provides accurate alignment validation through an electronic display, at the site of the knee replacement surgery.

The technology enables surgeons to easily perform joint replacement procedures as the iASSIST Knee technology provides accurate intraoperative feedback required for such procedures, said Zimmer in a statement.

Jeff McCaulley, President of Zimmer Reconstructive stated, "This technology supports more streamlined and personalized knee replacement procedures through a simple, disposable intraoperative device and delivers accurate implant positioning and alignment validation without the complexity, cost and time associated with current intensive navigation and robotic systems."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Netflix Inc. and movie studio Disney are finally taking their deal that was announced in 2012 to the next level. The online movie rental service will become the exclusive U.S. pay-TV home of the latest films from Disney, Marvel, Lucasfilm and Pixar. Abercrombie & Fitch Co. (ANF) reported a GAAP net loss attributable to company of $39.6 million for the first quarter ended April 30, 2016 compared to a loss of $63.2 million, last year. Excluding certain items last year, net loss attributable to Abercrombie & Fitch Co. increased $2.4 million. Net... Dollar General Corp. (DG) reported first-quarter net income of $295 million, or $1.03 per share compared to $253 million, or $0.84 per share, a year ago. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $0.95 for the quarter. Analysts' estimates typically...
comments powered by Disqus
Follow RTT